| Recommendations—diagnosis . | LoE . | Grade . |
|---|---|---|
| Restrict diagnosis of TD to men with persistent symptoms suggesting TD and confirmed low T | 3 | C |
| Measure fasting T levels in the morning before 11 am, acknowledging that, in normal life, non-fasting levels could be up to 30% lower | 2 | A |
| Repeat TT assessment on ≥2 occasions by a reliable method; in addition, measure FT in men with levels close to the lower normal range (8–12 nmol/L) or those with suspected or known abnormal SHBG levels | 1 | A |
| Measure LH serum levels to differentiate primary from secondary TD | 2 | A |
| Base decisions on therapy on published action levels rather than laboratory reference ranges | 4 | B |
| Recommendations—diagnosis . | LoE . | Grade . |
|---|---|---|
| Restrict diagnosis of TD to men with persistent symptoms suggesting TD and confirmed low T | 3 | C |
| Measure fasting T levels in the morning before 11 am, acknowledging that, in normal life, non-fasting levels could be up to 30% lower | 2 | A |
| Repeat TT assessment on ≥2 occasions by a reliable method; in addition, measure FT in men with levels close to the lower normal range (8–12 nmol/L) or those with suspected or known abnormal SHBG levels | 1 | A |
| Measure LH serum levels to differentiate primary from secondary TD | 2 | A |
| Base decisions on therapy on published action levels rather than laboratory reference ranges | 4 | B |
| Recommendations—diagnosis . | LoE . | Grade . |
|---|---|---|
| Restrict diagnosis of TD to men with persistent symptoms suggesting TD and confirmed low T | 3 | C |
| Measure fasting T levels in the morning before 11 am, acknowledging that, in normal life, non-fasting levels could be up to 30% lower | 2 | A |
| Repeat TT assessment on ≥2 occasions by a reliable method; in addition, measure FT in men with levels close to the lower normal range (8–12 nmol/L) or those with suspected or known abnormal SHBG levels | 1 | A |
| Measure LH serum levels to differentiate primary from secondary TD | 2 | A |
| Base decisions on therapy on published action levels rather than laboratory reference ranges | 4 | B |
| Recommendations—diagnosis . | LoE . | Grade . |
|---|---|---|
| Restrict diagnosis of TD to men with persistent symptoms suggesting TD and confirmed low T | 3 | C |
| Measure fasting T levels in the morning before 11 am, acknowledging that, in normal life, non-fasting levels could be up to 30% lower | 2 | A |
| Repeat TT assessment on ≥2 occasions by a reliable method; in addition, measure FT in men with levels close to the lower normal range (8–12 nmol/L) or those with suspected or known abnormal SHBG levels | 1 | A |
| Measure LH serum levels to differentiate primary from secondary TD | 2 | A |
| Base decisions on therapy on published action levels rather than laboratory reference ranges | 4 | B |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
